Search

Aim: The real‐world benefits of continuous glucose monitoring (CGM) in the broad type 2 diabetes (T2D) population are not well studied. Our study evaluated the impact of CGM use on health care resource utilization over 12 months in adults with T2D. Materials and Methods: This retrospective cohort analysis used Optum's de‐identified Market Clarity data of >79 million people to evaluate CGM use in people with T2D who were treated with non‐insulin (NIT), basal insulin (BIT) and prandial insulin therapy (PIT). The primary outcomes were changes in all‐cause hospitalizations, acute diabetes‐related hospitalizations and acute diabetes‐related emergency room visits during the 6‐ and 12‐month post‐index period following transition from blood glucose monitoring to CGM. A pre‐specified subgroup analysis assessed glucose control and medication changes among people with T2D over 1 year. Results: The analysis included 74 679 adults with T2D (NIT; n = 25 269), (BIT; n = 16 264) and (PIT; n = 33 146). Significant reductions in all‐cause hospitalizations, acute diabetes‐related hospitalizations and acute diabetes‐related emergency room visits were observed in the 6‐month post‐index period that were sustained during the 6–12 month post‐index period (NIT, −10.1%, −31.0%, −30.7%; BIT, −13.9%, −47.6%, −28.2%; and PIT, −22.6%, −52.7%, −36.6%, respectively). A subgroup analysis of 6030 people showed mean glycated haemoglobin reductions at approximately 3 months, which were also sustained throughout the post‐index period: NIT, −1.1 (0.05)%; BIT, −1.1 (0.06)%; and PIT, −0.9 (0.04)%, p < 0.0001. Conclusions: CGM use in real‐life across different therapeutic regimens in adults with T2D was associated with reductions in health care resource utilization with improved glucose control over 1 year. [ABSTRACT FROM AUTHOR]

Introduction Material and Methods Results Conclusions Self‐monitoring of blood glucose (SMBG) is the standard of care for women with gestational diabetes mellitus (GDM). This study aimed to review SMBG profiles in women with GDM and to examine how glucose metrics derived from SMBG relate to fetal overgrowth and infants born large for gestational age (LGA, >90th percentile).This was a single‐center, historical, observational cohort study of 879 GDM pregnancies in Sweden. The diagnosis of GDM was based on a universal 75 g oral glucose tolerance test at gestational week 28 or 12 in high‐risk women. The glucose metrics derived from the SMBG profiles were calculated. Treatment targets for glucose were <5.3 mmol/L fasting, and ≤7.8 mmol/L 1‐h postprandial. The median (interquartile range) number of glucose measurements in the analysis for each woman was 318 (216–471), including 53 (38–79) fasting glucose measurements. Associations between glucose metrics and LGA were analyzed using binary logistic regression analysis adjusted for maternal age, body mass index, smoking, nulliparity, and European/non‐European origin. Receiver operating characteristic (ROC) curves were used to evaluate glucose levels for LGA prediction. Differences in means were tested using analysis of variance.The proportion of LGA infants was 14.6%. Higher mean glucose levels and smaller proportion of readings in target (glucose 3.5–7.8 mmol/L) were significantly associated with LGA (odds ratio [95% confidence interval]: 3.06 [2.05–4.57] and 0.94 [0.92–0.96], respectively). The strongest association was found with mean fasting glucose (3.84 [2.55–5.77]). The ability of mean fasting glucose and overall mean glucose to predict LGA infants in the ROC curves was fair, with areas under the curve of 0.738 and 0.697, respectively (p < 0.001). The corresponding discriminating thresholds were 5.3 and 6.1 mmol/L, respectively. Mean glucose levels increased and readings in target decreased with increasing body mass index category and at each step of adding pharmacological treatment, from diet alone to metformin and insulin (p < 0.001).Higher mean glucose levels and a smaller proportion of readings within the target range were associated with an increased risk of LGA. Suboptimal glucose control is associated with obesity and the need for pharmacological treatment. [ABSTRACT FROM AUTHOR]

AbstractHelicobacter pylori infection has been associated with the development of insulin resistance (IR). This study aimed to examine the effect of H. pylori-derived extracellular vesicles (EVs) on IR induction. EVs were derived from two H. pylori strains, and characterised by transmission electron microscopy and dynamic light scattering. Different concentrations of insulin were added to HepG2 cells to induce IR model. HepG2 cells were exposed to various concentrations of H. pylori-derived EVs to assess IR development. The gene expression of IRS1, AKT2, GLUT2, IL-6, SOCS3, c-Jun and miR-140 was examined using RT-qPCR. Glucose uptake analysis revealed insulin at 5 × 10 −7 mol/l and EVs at 50 µg/ml induced IR model in HepG2 cells. H. pylori-derived EVs downregulated the expression level of IRS1, AKT2, and GLUT2, and upregulated IL-6, SOCS3, c-Jun, and miR-140 expression in HepG2 cells. In conclusion, our findings propose a novel mechanism by which H. pylori-derived EVs could potentially induce IR. [ABSTRACT FROM AUTHOR]

Introduction: Neurobrucellosis (NB) can be associated with meningitis and present as a headache with or without meningeal signs. Pseudotumor presentation of NB has been reported to be accompanied by lymphocytic predominant cerebrospinal fluid(CSF) pleocytosis. NB is diagnosed by means of isolation of Brucella from blood or CSF and/or the presence of anti-Brucella antibodies in the CSF. Molecular techniques have been used in chronic or challenging cases of NB. Clinical findings: We report on seven cases of NB presenting with different types of headache and signs of meningeal involvement. In five cases, signs of intracranial hypertension were evident in the form of papilledema, sixth nerve palsy and blurred vision. Diagnosis: MRIs of the brain revealed signs of intracranial hypertension in three patients, basal meningeal enhancement in one patient and white matter lesions in one patient. Brucella serology in the blood and CSF was negative in all patients. It was interesting that four patients had normocellular CSF analysis with normal glucose and protein results. The diagnosis was made by Brucella PCR in all patients. Conclusion: NB should be considered in the differential diagnoses of pseudotumor cerebri syndrome in endemic areas. It is important to employ molecular techniques using sterile CSF samples in the investigation of Brucella. [ABSTRACT FROM AUTHOR]

Metal‐organic frameworks (MOFs) are porous materials with numerous chemical and structural possibilities. Due to their ease of modification, well‐organized structure, and diverse guest molecule chemistry, MOFs are ideal platforms for uncovering improved functional material design characteristics. Quantitative analysis of glucose is crucial, especially in some food products, for quality control as well as evaluation of the glucose levels helps diagnose and treat diabetes. Recent glucose sensing devices have relied heavily on MOFs and other nanomaterials to enable user‐friendly and safe non‐invasive sensing methods. Nevertheless, the conventional synthesis methods involve multi‐day reactions, cooling, and depressurization processes. This study demonstrates the unprecedented high‐power laser‐induced rapid synthesis (LIRS) of Ni‐based MOF nanospheres with interconnected nano‐rods and noncentrosymmetric primitive triclinic crystalline structure, highlighting their multifunctional usage in sensing and gas sorption applications. Ab initio simulations show excellent agreement with the experimental physical and gas sorption properties. Furthermore, the Ni‐MOF‐based biosensor accurately measures glucose real‐life beverage samples, yielding promising glucose detection biosensor results with a low limit of the detection (LOD) of 13.96 µM and high sensitivity of 120.606 µA mM−1 cm−2. [ABSTRACT FROM AUTHOR]

[Display omitted] As different monosaccharides exhibit different redox characteristics, this paper presented a novel colorimetric sensor array based on the glucose oxidase-like (GOx-like) activity of Au nanoparticles (NPs) for monosaccharides identification. AuNPs can use O 2 , ABTS+•, or [Ag(NH 3) 2 ]+ as an electron acceptor to catalyze the oxidation of monosaccharides in different velocity, resulting in cross-responsive signals. The current sensor array can distinguish between different monosaccharides or their mixtures through linear discriminant analysis (LDA) and hierarchical clustering analysis (HCA). Moreover, the glucose and fructose concentrations can be estimated simultaneously using a neural network regression model based on the sensor array. This method shows potential for monosaccharide detection in industrial, medical, and biological applications. [ABSTRACT FROM AUTHOR]

Simple Summary: It is vitally important that methods to combat climate change-induced effects on water availability are studied in agriculture. We have previously determined the voluntary water usage of modern broilers and, in this article, further explore the molecular differences between meat-type chickens that consume more or less water than average. We show here that sugar metabolites and the expression of glucose transporter genes in the kidneys are different between these birds. These differences can aid in the selection of birds that drink less water than average for the same feed intake and body weight gain. This could help reduce the use of water in the poultry industry. Molecular differences exist between birds with high residual water intake (HRWI) compared to those with low residual water intake (LRWI). Residual water intake (RWI) is defined as the difference between the water intake of a bird and the expected water intake corrected for metabolic body weight, feed intake, and body weight gain. Tissue metabolomic analysis revealed significantly increased kidney glucose, fructose, and arabitol in the LRWI group compared to the HRWI group. mRNA expression analysis of apical sodium glucose cotransporters SGLT1, SGLT4, SGLT5, and SGLT6 showed decreased expression of SGLTs 1, 5, and 6 in LRWI birds (p < 0.05), whereas SGLT4 expression was increased compared with HRWI birds (p < 0.01). An analysis of basal glucose transporters GLUT1, GLUT2, GLUT5, and GLUT9 showed significantly increased GLUT2 expression in LRWI birds compared with HRWI birds (p < 0.01). We postulate that SGLT4 is the main apical transporter in chicken kidneys and that its increased expression reduces these birds' need for water, resulting in less drinking. This is balanced by the increased expression of the basal transporter GLUT2, indicating better glucose retention, which may partly explain the physiological mechanism behind why these birds drink less water. Innately driven broiler water intake could therefore be influenced by the expression of kidney solute transporters. [ABSTRACT FROM AUTHOR]

The artificial pulsed-flows impact associated with hydropower production on the downstream biological and physical processes has been extensively addressed, showing that it may cause fish drift while changing fish habitat selection toward lower water velocity patches, acting as refuge areas. We aimed to evaluate the attraction efficiency of two flow-refuges differing in their approaching angles, for Luciobarbus bocagei at an indoor experimental flume. We tested two flow-refuge insertion angles (45° and 70°), and two flow events (base 7 L/s and pulsed-flow 60 L/s) for each. To analyze flow-refuge efficiency, we quantified fish individual and group patterns, flow-refuge use, and permanence time, while measuring glucose and lactate responses. The results showed that the individual frequency of use during simulated pulsed-flow was higher, especially on the 45° flow-refuge. The simulated pulsed-flow condition did not disrupt group behavior for both approaching angles. Glucose and lactate analysis did not trigger physiological responses in the tested trials. The 45° flow-refuge was used more often than the 70°. The narrowing of the channel caused by the 45° flow-refuge, and the consequent higher flow homogeneity increased the attractiveness of the flow-refuge. Therefore, the flow-refuge insertion angle should be a decisive criterion in the construction and installation of flow-refuges for cyprinids, and be considered a potential indirect mitigation measure. [ABSTRACT FROM AUTHOR]

Copyright of Turkish Journal of Trauma & Emergency Surgery / Ulusal Travma ve Acil Cerrahi Dergisi is the property of KARE Publishing and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Sweat glucose serves as a significant biomarker of health, necessitating accurate determination at the micromolar level for noninvasive monitoring. To address this need, we design an organic field‐effect transistor (OFET)‐based enzymatic sensor to quantify glucose levels in human sweat. The extended‐gate structure of the OFET device ensures stable analyte detection in human sweat owing to its isolated configuration. The extended‐gate‐type OFET has been functionalized with glucose oxidase and an N‐ethylphenazonium‐based mediator‐attached monolayer. This configuration facilitates electron relay, enabling accurate and reproducible glucose detection. Leveraging the amplification ability of the OFET, the enzymatic sensor exhibited highly sensitive glucose detection, achieving a low limit of detection (2.9 μM) suitable for sweat analysis requirements. In addition, the sensor exhibited high discriminability in detecting glucose amidst interferents commonly found in sweat, indicating its practical feasibility for sweat analysis. Validation of glucose recovery rates (95–105 %) in human sweat, without pretreatment, was performed using established instrumental analysis methods. [ABSTRACT FROM AUTHOR]

Until now, the external quality assessment (EQA) of glucose point-of-care testing (POCT) has lacked a high quality, suitable and commutable control material to assess measurement accuracy. Here we present a concept for determining the accuracy of glucose measurements, which uses human whole blood and does not require stabilising agents.This new generation of quality control samples uses a bead that contains a specific amount of glucose. The bead is then dissolved in a whole blood matrix by the EQA participant immediately before the POCT. We analysed its suitability as an EQA material with respect to its reproducibility, homogeneity and stability, and applied it in an EQA pilot study. The glucose target value was determined using the reference measurement procedure and served as an evaluation criterion for the accuracy of the EQA survey results.The homogeneity and stability of the new control material fulfilled the quality requirements of ISO 17043. Based on the reference measurement value for glucose, the results of the pilot EQA scheme showed a pass rate of 84.6 % for the participating POCT devices. The acceptance limit was a 15 % permitted deviation from the target value according to Rili-BAEK. All of the device collectives deviated from the target value by 0–4.4 % with the exception of one device type, which deviated by 21 %.The new concept offers, for the first-time, whole blood-based trueness controls for glucose POCT analysis for external quality assurance. The concept does not require the addition of any stabilising reagent and is easy to use. [ABSTRACT FROM AUTHOR]

Nanorod structures exhibit a high surface-to-volume ratio, enhancing the accessibility of electrolyte ions to the electrode surface and providing an abundance of active sites for improved electrochemical sensing performance. In this study, tetragonal α-MnO2 with a large K+-embedded tunnel structure, directly grown on microfibrous carbon paper to form densely packed nanorod arrays, is investigated as an electrocatalytic material for non-enzymatic glucose sensing. The MnO2 nanorods electrode demonstrates outstanding catalytic activity for glucose oxidation, showcasing a high sensitivity of 143.82 µA cm−2 mM−1 within the linear range from 0.01 to 15 mM, with a limit of detection (LOD) of 0.282 mM specifically for glucose molecules. Importantly, the MnO2 nanorods electrode exhibits excellent selectivity towards glucose over ascorbic acid and uric acid, which is crucial for accurate glucose detection in complex samples. For comparison, a gold electrode shows a lower sensitivity of 52.48 µA cm−2 mM−1 within a linear range from 1 to 10 mM. These findings underscore the superior performance of the MnO2 nanorods electrode in both sensitivity and selectivity, offering significant potential for advancing electrochemical sensors and bioanalytical techniques for glucose monitoring in physiological and clinical settings. [ABSTRACT FROM AUTHOR]

In healthcare, blood pH and glucose levels are critical indicators, especially for chronic conditions like diabetes. Although taking blood samples is accurate, it is invasive and unaffordable for many. Wearable sensors offer non‐invasive and continuous detection methods, yet face major challenges, such as high cost, inaccuracies, and complex interpretation. Colorimetric wearable sensors integrated with machine learning (ML) are introduced for accurately detecting pH values and glucose concentrations in sweat. These battery‐free and cost‐effective biosensors, made of cotton textiles, are designed to work seamlessly with smartphones for data collection and automated analysis. A new pH indicator is synthesized with enhanced sensitivity and two types of glucose sensors are developed by depositing enzymatic solutions onto cotton substrates. The sensors' performance is assessed using standard solutions with known pH levels ranging from 4 to 10 and glucose concentrations between 0.03 to 1 mm. The photos captured from these sensors are then analyzed by image processing and three different ML algorithms, achieving an accuracy of 90% in pH and glucose detection. These findings provide effective synthesis methods for textile‐based sweat sensors and demonstrate the significance of employing different ML algorithms for their colorimetric analysis, thus eliminating the need for human intervention in the process. [ABSTRACT FROM AUTHOR]

Effective continuous glucose monitoring solutions require consistent sensor performance over the lifetime of the device, a manageable variance between devices, and the capability of high volume, low cost production. Here we present a novel and microfabrication-compatible method of depositing and stabilizing enzyme layers on top of planar electrodes that can aid in the mass production of sensors while also improving their consistency. This work is focused on the fragile biorecognition layer as that has been a critical difficulty in the development of microfabricated sensors. We test this approach with glucose oxidase (GOx) and evaluate the sensor performance with amperometric measurements of in vitro glucose concentrations. Spincoating was used to deposit a uniform enzyme layer across a wafer, which was subsequently immobilized via glutaraldehyde vapor crosslinking and patterned via liftoff. This yielded an approximately 300 nm thick sensing layer which was applied to arrays of microfabricated platinum electrodes built on blank wafers. Taking advantage of their planar array format, measurements were then performed in high-throughput parallel instrumentation. Due to their thin structure, the coated electrodes exhibited subsecond stabilization times after the bias potential was applied. The deposited enzyme layers were measured to provide a sensitivity of 2.3 ± 0.2 μA mM−1 mm−2 with suitable saturation behavior and minimal performance shift observed over extended use. The same methodology was then demonstrated directly on top of wireless CMOS potentiostats to build a monolithic sensor with similar measured performance. This work demonstrates the effectiveness of the combination of spincoating and vapor stabilization processes for wafer scale enzymatic sensor functionalization and the potential for scalable fabrication of monolithic sensor-on-CMOS devices. [ABSTRACT FROM AUTHOR]

The present study aims to evaluate the effect of Sepia pharaonis ink on insulin resistance in PCOS-induced mice. Treatment with sepia ink in dehydroepiandrosterone (DHEA)-induced PCOS mice at various doses of 50 mg/kg, 100 mg/kg, and 200 mg/kg body weight mitigated the insulin resistance in the study groups with decreased concentration of testosterone and increased concentrations of estrogen and progesterone compared to the PCOS group tested by ELISA. The histopathological analysis and restoration of glucose analysis showed a significant reduction in treatment groups. Reduced expression of insulin resistance genes like androgen receptor (AR), insulin receptor substrate 1 (IRS-1), and insulin-like growth factor1 (IGF-1) by qRT-PCR indicate a positive impact of sepia ink in alleviating the symptoms associated with PCOS. Taken together, the results of this study indicate sepia ink as a promising therapeutic intervention and a possible drug target for insulin resistance in diabetes and gynecological disorders like PCOS. [ABSTRACT FROM AUTHOR]

A biocompatible, highly sensitive, and enzyme-free glucose electrochemical sensor was developed based on a copper-cysteamine (Cu-Cy)-modified electrode. The catalytically active biocompatible material Cu-Cy was immobilized on the electrode surface by the natural polymer chitosan (CTS). The electrochemical characterization and glucose response of the Cu-Cy/CTS/glassy carbon electrode (GCE) were investigated by electrochemical impedance spectroscopy (EIS), cyclic voltammetry (CV), and constant potential amperometry. The significant electrocatalytic activity of Cu-Cy to the oxidation of glucose in an alkaline environment was revealed. Several crucial parameters, including the number of scanning cycles for electrode activation, applied potential, and the contents of Cu-Cy and chitosan, were investigated to understand their impact on the sensor's response. The proposed sensing platform exhibited linear ranges of 2.7 μM to 1.3 mM and 1.3 mM to 7.7 mM for glucose detection, coupled with high sensitivity (588.28 and 124.42 μA·mM−1·cm−2), and commendable selectivity and stability. Moreover, a Cu-Cy/CTS-modified screen-printed electrode (SPE) was further developed for portable direct detection of glucose in real samples. [ABSTRACT FROM AUTHOR]

Saccharomyces cerevisiae cannot assimilate xylose, second to glucose derived from lignocellulosic biomass. Here, the engineered S. cerevisiae strains INVSc-XI and INVSc-XI/XT were constructed using xylA and Xltr1p to co-utilize xylose and glucose, achieving economic viability and sustainable production of fuels. The xylose utilization rate of INVSc-XI/XT was 2.3-fold higher than that of INVSc-XI, indicating that overexpressing Xltr1p could further enhance xylose utilization. In mixed sugar media, a small amount of glucose enhanced the consumption of xylose by INVSc-XI/XT. Transcriptome analysis showed that glucose increased the upregulation of acetate of coenzyme A synthetase (ACS), alcohol dehydrogenase (ADH), and transketolase (TKL) gene expression in INVSc-XI/XT, further promoting xylose utilization and ethanol yield. The highest ethanol titer of 2.91 g/L with a yield of 0.29 g/g at 96 h by INVSc-XI/XT was 56.9% and 63.0% of the theoretical ethanol yield from glucose and xylose, respectively. These results showed overexpression of xylA and Xltr1p is a promising strategy for improving xylose and glucose conversion to ethanol. Although the ability of strain INVSc-XI/XT to produce ethanol was not very satisfactory, glucose was discovered to influence xylose utilization in strain INVSc-XI/XT. Altering the glucose concentration is a promising strategy to improve the xylose and glucose co-utilization. HIGHLIGHTS: INVSc-XI and INVSc-XI/XT strains were newly constructed to utilize xylose and glucose. XylA, in combination with xylose transporter Xltr1p, enhances xylose consumption. A small amount of glucose enhanced xylose utilization in INVSc-XI/XT strain. The expression of ACS, ADH, and TKL genes is upregulated in the media containing mixed sugars. The highest ethanol yield of 0.29 g/g was produced in a 2-L scale-up fermenter. [ABSTRACT FROM AUTHOR]

This study reports a micromachined parylene-C-coated integrated electrode (IDE) sensor fabricated on a polyimide film. Glucose and uric acid within the human sweat concentration range were tested using hydrothermally grown ZnO nanoparticles (NPs) immobilized on the IDE regions of sensors and modified with urate oxidase and glucose oxidase enzymes. Four important sensing parameters, including capacitance, impedance, resistance, and phase, were simultaneously investigated during the dynamic test. The sensor fabrication and characterization of ZnO NPs and ZnO NP formed sensing film were described in detail. The experimental results show that the amount of capacitance change and phase change vs. the concentration variation of glucose and uric acid exhibits an excellent linear regression relationship. On the other hand, the amount of impedance change vs. concentration variation of glucose and uric acid exhibits a power regression relationship. Sensitivities of uric acid and glucose detection based on capacitance changes were 0.1131 pF/µM and 0.7875 pF/µM, respectively. Limits of detection of uric acid and glucose were 1.23 µM and 0.311 µM, respectively. Thus, the developed sensor can be applied to wearable devices for the quantitative analysis of sweat composition in the future. [ABSTRACT FROM AUTHOR]

Aim: To quantify the physiological demands and impact of muscle function t of the Fran workout, one of the most popular CrossFit benchmarks. Methods: Twenty experienced CrossFitters—16 male: 29 (6) years old and 4 female: 26 (5) years old— performed 3 rounds (with 30-s rests in between) of 21–21, 15–15, and 9–9 front squats to overhead press plus pull-up repetitions. Oxygen uptake and heart rate were measured at baseline, during the workout, and in the recovery period. Rating of perceived exertion, blood lactate, and glucose concentrations were assessed at rest, during the intervals, and in the recovery period. Muscular fatigue was also monitored at rest and at 5 minutes, 30 minutes, and 24 hours postexercise. Repeated-measures analysis of variance was performed to compare time points. Results: Aerobic (52%–29%) and anaerobic alactic (30%–23%) energy contributions decreased and the anaerobic lactic contribution increased (18%–48%) across the 3 rounds of the Fran workout. Countermovement jump height decreased by 8% (−12 to −3) mean change (95% CI), flight duration by 14% (−19 to −7), maximum velocity by 3% (−5 to −0.1), peak force 4% (−7 to −0.1), and physical performance (plank prone 47% [−54 to −38]) were observed. Conclusions: It appears that the Fran workout is a physically demanding activity that recruits energy from both aerobic and anaerobic systems. This severe-intensity workout evokes substantial postexercise fatigue and corresponding reduction in muscle function. [ABSTRACT FROM AUTHOR]

ZnFe (PBA)@Mo3C2Tx is prepared by in‐situ sonication method using ZnFe Prussian blue analogue infused with Mo3C2Tx (MXene) to use as a non‐enzymatic glucose sensor owing to its low cost and biocompatibility. The synthesized ZnFe (PBA)@Mo3C2Tx is characterized for its physical and chemical characterization by XRD, Raman, XPS, EDAX, and FESEM analyses, revealing a functionalized multiple‐layered structure with a cubic nano‐hybrid arrangement. This sensor has undergone electroanalytical investigation, including cyclic voltammetry and chronoamperometry analysis. The electrochemical performance of ZnFe(PBA)@Mo3C2Tx exhibits an excellent analytical performance with a sensitivity of 818.285 μA mM−1 cm−2 and the limit of detection (LOD) of 1.6 μM (S/N=3). The analysis of glucose in human sweat samples, compared with their corresponding blood glucose values, yield a relative standard deviation (RSD) of 2.98 %. [ABSTRACT FROM AUTHOR]

Diabetes is a common chronic metabolic disease with a wide range of clinical symptoms and consequences and one of the main causes of death. For the management of diabetes, painless and continuous interstitial fluid (ISF) glucose monitoring is ideal. Here, we demonstrate continuous diabetes monitoring using an integrated microneedle (MN) biosensor with an emergency alert system. MNs are a novel technique in the field of biomedical engineering because of their ability to analyze bioinformation with minimal invasion. In this work we developed a poly(methyl methacrylate) (PMMA) based MN glucose sensor. The device was produced by the 3D printing technique, microfabrication, electrodeposition, and enzyme immobilization step. The in vitro test for the glucose MN sensor showed a linear range from 1.5 to 14 mM with a sensitivity of 1.51 μA mM−1, limit of detection (LOD) of 0.35 mM and good selectivity. Highly repeatable sensing is observed with good reproducibility. The interference-free detection of glucose in the presence of physiologically relevant concentrations of ascorbic acid, uric acid, and mannose is demonstrated, along with the operational stability of the array. After resolving the biofouling consequences linked to on-body sensing, this MN platform would be appealing for minimally invasive electrochemical glucose monitoring. An alert is sent to confidants via email or SMS when the values are abnormal. The application is also able to display the recorded values in the form of a graph to help determine the state of health of the user over a period of time. It can be concluded that continuous monitoring and an emergency alert system are important for keeping an eye on diabetic patients and can send alert in case of an abnormal situation of the patient. [ABSTRACT FROM AUTHOR]

This work focuses on studying high-codimensional bifurcations in the glucose model with obesity’s effect. We examine the related dynamical behaviors, taking into account the risk and adverse health effects associated with obesity’s impact on the glucose model. Through the application of the normal form method, we demonstrate that the model exhibits codimension-1 and codimension-2 bifurcations such as saddle node bifurcation and cusp bifurcation. Additionally, we introduce and prove a theorem that establishes the presence of Hopf bifurcation in the model. The computation of the first Lyapunov coefficient is achieved using center manifold theory. To support our theoretical analysis and showcase the model’s complex dynamical behaviors, including periodic curve families, we provide numerical simulations. These simulations contribute to understanding clinical observations regarding the effects of obesity on glucose levels, oscillations and disorders. Ultimately, this research can aid in the early control of blood glucose levels. [ABSTRACT FROM AUTHOR]

Helicobacter pylori (H. pylori) infection is the primary risk factor for the pathogenesis of gastric cancer (GC). N6‐methyladenosine (m6A) plays pivotal roles in mRNA metabolism and hnRNPA2B1 as an m6A reader is shown to exert m6A‐dependent mRNA stabilization in cancer. This study aims to explore the role of hnRNPA2B1 in H. pylori‐associated GC and its novel molecular mechanism. Multiple datasets and tissue microarray are utilized for assessing hnRNPA2B1 expression in response to H. pylori infection and its clinical prognosis in patients with GC. The roles of hnRNPA2B1 are investigated through a variety of techniques including glucose metabolism analysis, m6A‐epitranscriptomic microarray, Ribo‐seq, polysome profiling, RIP‐seq. In addition, hnRNPA2B1 interaction with poly(A) binding protein cytoplasmic 1 (PABPC1) is validated using mass spectrometry and co‐IP. These results show that hnRNPA2B1 is upregulated in GC and correlated with poor prognosis. H. pylori infection induces hnRNPA2B1 upregulation through recruiting NF‐κB to its promoter. Intriguingly, cytoplasm‐anchored hnRNPA2B1 coordinated PABPC1 to stabilize its relationship with cap‐binding eIF4F complex, which facilitated the translation of CIP2A, DLAT and GPX1 independent of m6A modification. In summary, hnRNPA2B1 facilitates the non‐m6A translation of epigenetic mRNAs in GC progression by interacting with PABPC1‐eIF4F complex and predicts poor prognosis for patients with GC. [ABSTRACT FROM AUTHOR]

In this study, a new amperometric biosensor was developed for glucose determination. For this purpose, polyaniline–polypyrrole–poly(sodium‐4‐styrenesulfonate) film was prepared by electropolymerization of aniline and pyrrole with poly(sodium‐4‐styrenesulfonate) on a platinum plate. The best working conditions of the polyaniline–polypyrrole–poly(sodium‐4‐styrenesulfonate) film were determined. The glucose oxidase enzyme was immobilized by the entrapment method in polyaniline–polypyrrole–poly(sodium‐4‐styrenesulfonate) film. Glucose determination was made based on the oxidation of hydrogen peroxide, which is formed as a result of the enzymatic reaction on the surface of the prepared biosensor at +0.40 V. The working range for the glucose determination of the biosensor was determined. The effects of pH and temperature on the response of the glucose biosensor were investigated. The reusability and shelf life of the biosensor were determined. The effects of interference in biological environments on the response of the biosensor were investigated. Glucose determination was made in the biological fluid (blood) with the prepared biosensor. This study has a feature that sheds light on biosensor studies to be developed for the detection of substances in the human body, such as glucose, uric acid, and urea. This article will set an example for future scientific research on the development of a sensor for other biological fluids in the human body, such as the sensor developed for blood samples. In addition, this developed sensor provides an innovation that improves the quality of life of patients by allowing them to constantly monitor their glucose levels and intervene when necessary. [ABSTRACT FROM AUTHOR]

Increased health awareness has called for better health monitoring devices, resulting in continuous research and advancement in glucose sensors. Innovations in both enzymatic and enzyme-free sensors (or non-enzymatic) are revolutionising diabetes control. While enzymatic sensors offer superior sensitivity and selectivity, enzyme-free sensors are preferred for stability and affordability, advancing the quest for rapid and accurate glucose tests. Progress in the development of enzyme-free glucose sensors is being achieved by improvements in electrode materials as well as sensor design. The selection of electrode materials is crucial in these sensors for attaining optimum values of sensing time as well as accuracy. Numerous electrode materials, including graphene, carbon nanotubes, metal oxides (such as platinum and gold), and conductive polymers, have been developed and studied by researchers to be employed in glucose sensors. Among the most critical factors being considered for developing glucose sensor materials is the selectivity for glucose molecules without interference due to the presence of another molecule. This article focuses on tracing recent developments in enzyme-free glucose sensor research, highlighting efforts to overcome limitations and drive innovation in glucose monitoring technology. [ABSTRACT FROM AUTHOR]

Over the past two decades, diabetes pharmacopoeia has flourished, with new drugs that, on top of their glucose‐lowering efficacy, have been shown to protect the heart and the kidney. Despite these new opportunities, metformin retains a pivotal role among glucose‐lowering agents. As one of the few available insulin sensitizers, metformin is an effective, safe, and overall well‐tolerated drug backed by over 60 years of clinical experience, including evidence for potential benefits beyond glucose reduction across different ages, sexes, genetic backgrounds, geographical areas, and stages of disease. Although there is some discussion of whether metformin offers the most effective front‐line option in newly diagnosed type 2 diabetes (T2D), it remains a natural companion to all other glucose‐lowering agents. Furthermore, metformin comes at a very low cost and, as such, it has extremely high cost‐effectiveness, particularly given the serious economic burden associated with diabetes complications. This financial advantage is particularly relevant in resource‐constrained healthcare systems, where the affordability of metformin may be instrumental in implementing an effective treatment in an evergrowing number of individuals. We present here compelling real‐world evidence in support of the clinical efficacy and cost‐effectiveness of metformin across different patient populations, highlighting areas where more population‐based studies are needed to further incorporate and consolidate its use in the pharmacological management of T2D. [ABSTRACT FROM AUTHOR]

Regular monitoring of blood glucose levels is crucial in diabetes management. Commonly used procedures may be invasive and can lead to cross-infection and inflammation. Therefore, a safe, non-invasive blood glucose-monitoring technology is needed. Herein, a 3D reduced graphene oxide (rGO) electrode was modified with MXene (Ti3C2) and gold nanoparticles (AuNPs) to construct a non-invasive, saliva glucose detection electrode. The Au/rGO-Ti3C2 electrode exhibited good detection performance for glucose concentrations in the range of 10 µM–21 mM at a working potential of 0.6 V, with a detection limit of 3.1 µM glucose, and a sensitivity of 355 µA mM−1 cm−2. The Au/rGO-Ti3C2 electrode showed almost no response to the addition of interfering substances, and no effect was observed upon subsequent glucose detection. The sensor could detect glucose in artificial saliva and saliva supernatant. The modified electrode showed a significant response to low glucose concentrations, even at 10 µM. These results indicate the suitability of the Au/rGO-Ti3C2 electrode for saliva glucose detection. The electrode developed in this study has great potential in improving the efficiency of diabetes monitoring through pain-free, non-invasive glucose detection in saliva. [ABSTRACT FROM AUTHOR]

Ti3C2Tx MXene/CuxO composites were prepared by acid etching combined with electrochemical technique. The abundant active sites on the surface of MXene greatly increase the loading of CuxO nanoparticles, and the synergistic effect between the different components of the composite can accelerate the oxidation reaction of glucose. The results indicate that at the working potential of 0.55 V (vs. Ag/AgCl), the glucose sensor based on Ti3C2Tx MXene/CuxO composite presents large linear concentration ranges from 1 µM to 4.655 mM (sensitivity of 361 µA mM−1 cm−2) and from 5.155 mM to 16.155 mM (sensitivity of 133 µA mM−1 cm−2). The limit of detection is 0.065 µM. In addition, the sensor effectively avoids the oxidative interference of common interfering species such as ascorbic acid, dopamine and uric acid. The sensor has good reproducibility, stability and acceptable recoveries for the detection of glucose in human sweat sample (97.5-103.3%) with RSD values less than 4%. Based on these excellent properties it has great potential for the detection of glucose in real samples. [ABSTRACT FROM AUTHOR]

The increasing prevalence of wearable devices has sparked a growing interest in real‐time health monitoring and physiological parameter tracking. This study focuses on the development of a cost‐effective sweat analysis device, utilizing microfluidic technology and selective electrochemical electrodes for non‐invasive monitoring of glucose and potassium ions. The device, through real‐time monitoring of glucose and potassium ion levels in sweat during physical activity, issues a warning signal when reaching experimentally set thresholds (K+ concentration at 7.5 mM, glucose concentrations at 60 μM and 120 μM). This alerts users to potential dehydration and hypoglycemic conditions. Through the integration of microfluidic devices and precise electrochemical analysis techniques, the device enables accurate and real‐time monitoring of glucose and potassium ions in sweat. This advancement in wearable technology holds significant potential for personalized health management and preventive care, promoting overall well‐being, and optimizing performance during physical activities. [ABSTRACT FROM AUTHOR]

Diabetes is a metabolic disease that seriously endangers human health, and monitoring glucose levels is one of the main diagnostic methods for its prevention and treatment. In this paper, we propose a high-performance glucose sensor based on the Sagnac interferometer (SI) utilizing photonic crystal fiber (PCF) with micro-holes. By setting two columns of micro-holes in the center of the PCF, the high birefringence effect is obtained to improve the detection sensitivity. All air holes are assumed to fill with the glucose solution, and the sensing characteristics of the PCF sensor are theoretically studied by the finite element method (FEM). The results show that the sensitivity and resolution of the PCF glucose sensor can reach 4.14 nm/(g/L) and 0.48 mg/dL within the concentration range of 0–120 g/L, respectively. In addition, the effects of the partial-filling methods and PCF structural parameters on the sensing performance are also analyzed to achieve optimal performance. The proposed glucose sensor possesses high sensitivity and simple structure, which exhibits good application prospects in the field of medical monitoring. [ABSTRACT FROM AUTHOR]

Although an enzymatic electrochemical biosensor is a major keystone in Diabetes Mellitus management, its replacement with a low-cost and stable non-enzymatic glucose sensor (NEGS) is of high interest to scientific and industrial fields. However, most NEGS for direct glucose electrooxidation (DGE) must be performed under extreme alkaline conditions, implying additional pretreatments before detection and a limited application for on-body, real-time monitoring. Thus, research on DGE in physiological conditions is fundamental to successfully translating the current NEGS into clinical applications. In physiological conditions, drawbacks such as low current, low selectivity, and poisoning appear due to the reduction of OH ions in neutral electrolytes and the presence of chloride ions in biofluids. Therefore, an increasing number of nanomaterials based on Pt, Au, and their nanocomposites have been proposed to improve the electrochemical performance. Additionally, transition metals such as Cu, Pd, Ni, or Co combined with high surface area supports have shown promising results in increasing catalytic sites for DGE. The molecular interaction of phenylboronic acid with glucose has also been demonstrated in neutral conditions. Overall, the present review summarizes the current strategies for DGE in physiological conditions and highlights the challenges still faced for further development of functional glucose NEGS. [ABSTRACT FROM AUTHOR]

Nanoparticles that catalyze biochemically relevant reactions are promoted as alternative enzymes. The application of such artificial enzymes is severely restricted by poor selectivity in biological fluids; mainly because the reactions occur at active sites on the exterior surface of the nanoparticle. Enzymes in contrast typically have their active sites down a nanoconfined substrate channel where the reaction occurs in different solution conditions to bulk solution which aids in achieving selectivity for the substrate. Herein the same 3D structure of enzymes is mimicked in nanoparticles to allow selective reactions in biological fluids. This is achieved using a gold nanoparticle coated in a conducting mesoporous carbon shell where isolated nanochannels lead to the gold surface. It can detect glucose in whole blood with no interference from other species. This is achieved by electrochemically pulsing the artificial enzymes to generate the locally required alkalinity for an effective electrocatalytic reaction in the nanochannels, as well as expelling fouling agents that will otherwise passivate the electrocatalytic reaction. The artificial enzymes are shown to be capable of detecting glucose in biological fluids, without loss of signal, for several months. This study shows how nanoconfinement in nanoparticles can be exploited to potentially allow a broad range of species to be selectively detected in biological fluids with stability that can exceed that of enzymes. [ABSTRACT FROM AUTHOR]

Wearable sensors, specifically microneedle sensors based on electrochemical methods, have expanded extensively with recent technological advances. Today's wearable electrochemical sensors present specific challenges: they show significant modulus disparities with skin tissue, implying possible discomfort in vivo, especially over extended wear periods or on sensitive skin areas. The sensors, primarily based on polyethylene terephthalate (PET) or polyimide (PI) substrates, might also cause pressure or unease during insertion due to the skin's irregular deformation. To address these constraints, we developed an innovative, wearable, all-fiber-structured electrochemical sensor. Our composite sensor incorporates polyurethane (PU) fibers prepared via electrospinning as electrode substrates to achieve excellent adaptability. Electrospun PU nanofiber films with gold layers shaped via thermal evaporation are used as base electrodes with exemplary conductivity and electrochemical catalytic attributes. To achieve glucose monitoring, gold nanofibers functionalized by gold nanoflakes (AuNFs) and glucose oxidase (GOx) serve as the working electrode, while Pt nanofibers and Ag/AgCl nanofibers serve as the counter and reference electrode. The acrylamide-sodium alginate double-network hydrogel synthesized on electrospun PU fibers serves as the adhesive and substance-transferring layer between the electrodes. The all-fiber electrochemical sensor is assembled layer-by-layer to form a robust structure. Given the stretchability of PU nanofibers coupled with a high specific surface area, the manufactured porous microneedle glucose sensor exhibits enhanced stretchability, superior sensitivity at 31.94 μA (lg(mM))−1 cm−2, a broad detection range (1–30 mM), and a significantly low detection limit (1 mM, S/N = 3), as well as satisfactory biocompatibility. Therefore, the novel electrochemical microneedle design is well-suited for wearable or even implantable continuous monitoring applications, thereby showing promising significant potential within the global arena of wearable medical technology. [ABSTRACT FROM AUTHOR]

The epimerization of glucose into mannose is of great significance for high-value utilization of monosaccharides. Extensive studies on the epimerization of glucose into mannose have been conducted using molybdenum-based catalysts, owing to their good activities for the epimerization reaction. Nonetheless, a great challenge for this reaction is that molybdenum species are prone to leaching into solution, which is a primary reason for catalyst deactivation. Additionally, the reaction usually gives a very low mannose yield and poor selectivity because it is a thermodynamic equilibrium reaction with sugar prone to side reactions at high temperatures. Herein, a metal–organic framework (MOF) material incorporating Keggin-type phosphomolybdate was explored as the catalyst for the epimerization of glucose. Under optimal conditions, an excellent mannose yield of up to 32.5% with an impressive selectivity of 94% was achieved. When other aldoses such as arabinose were used as starting materials, the catalyst also afforded high yield and product selectivity in the epimerization reaction. This novel hybrid material, a polyoxometalate-based metal–organic framework (POMOF), has been introduced to catalyze the conversion of sugars for the first time. Notably, in contrast to most molybdenum-based catalysts, the target hybrid showed good stability after five successive cycles. Furthermore, the reaction mechanism of the glucose-to-mannose epimerization was proposed, confirming the intramolecular carbon-skeleton rearrangement pathway (involving C-1 and C-2 positions) by isotope-labeling trace experiments. [ABSTRACT FROM AUTHOR]

The glucose level in the blood is measured through invasive methods, causing discomfort in the patient, loss of sensitivity in the area where the sample is obtained, and healing problems. This article deals with the design, implementation, and evaluation of a device with an ESP-WROOM-32D microcontroller with the application of near-infrared photospectroscopy technology that uses a diode array that transmits between 830 nm and 940 nm to measure glucose levels in the blood. In addition, the system provides a webpage for the monitoring and control of diabetes mellitus for each patient; the webpage is hosted on a local Linux server with a MySQL database. The tests are conducted on 120 people with an age range of 35 to 85 years; each person undergoes two sample collections with the traditional method and two with the non-invasive method. The developed device complies with the ranges established by the American Diabetes Association: presenting a measurement error margin of close to 3% in relation to traditional blood glucose measurement devices. The purpose of the study is to design and evaluate a device that uses non-invasive technology to measure blood glucose levels. This involves constructing a non-invasive glucometer prototype that is then evaluated in a group of participants with diabetes. [ABSTRACT FROM AUTHOR]

Objective: To evaluate postprandial glucose control when applying (1) faster-acting insulin aspart (Fiasp) compared to insulin aspart and (2) ultra-rapid insulin lispro (Lyumjev) compared to insulin lispro using the CamAPS FX hybrid closed-loop algorithm. Research Design and Methods: We undertook a secondary analysis of postprandial glucose excursions from two double-blind, randomized, crossover hybrid closed-loop studies contrasting Fiasp to standard insulin aspart, and Lyumjev to standard insulin lispro. Endpoints included incremental area under curve (iAUC)-2h, iAUC-4h, 4 h postprandial time in target range, time above range, and time below range. It was approved by independent research ethics committees. Results: Two trials with 8 weeks of data from 51 adults with type 1 diabetes were analyzed and 7137 eligible meals were included. During Lyumjev compared with insulin lispro, iAUC-2h and iAUC-4h were significantly decreased following breakfast (mean difference 92 mmol/L per 2 h (95% confidence interval [CI]: 56 to 127); P < 0.001 and 151 mmol/L per 4 h (95% CI: 74 to 229); P < 0.001, respectively) and the evening meal (P < 0.001 and P = 0.011, respectively). Mean time in target range (3.9–10.0 mmol/L) for 4 h postprandially significantly increased during Lyumjev with a mean difference of 6.7 percentage points (95% CI: 3.3 to 10) and 5.7 percentage points (95% CI: 1.4 to 9.9) for breakfast and evening meal, respectively. In contrast, there were no significant differences in iAUC-2h, iAUC-4h, and the other measures of postprandial glucose control between insulin aspart and Fiasp during breakfast, lunch, and evening meal (P > 0.05). Conclusion: The use of Lyumjev with CamAPS FX closed-loop system improved postprandial glucose excursions compared with insulin lispro, while the use of Fiasp did not provide any advantage compared with insulin aspart. Clinical Trial Registration numbers: NCT04055480, NCT05257460. [ABSTRACT FROM AUTHOR]

Graphene and its variants exhibit excellent electrical properties for the construction of enzymatic interfaces. In particular, the direct electron transfer of glucose oxidase on the electrode surface is a very important issue in the development of enzyme-based bioelectrodes. However, the number of studies conducted to assess how pristine graphene forms different interfaces with other carbon materials is insufficient. Enzyme-based electrodes (formed using carbon materials) have been extensively applied because of their low manufacturing costs and easy production techniques. In this study, the characteristics of a single-walled carbon nanotube/graphene-combined enzyme interface are analyzed at the atomic level using molecular dynamics simulations. The morphology of the enzyme was visualized using an elastic network model by performing normal-mode analysis based on electrochemical and microscopic experiments. Single-carbon electrodes exhibited poorer electrical characteristics than those prepared as composites with enzymes. Furthermore, the composite interface exhibited 4.61- and 2.45-fold higher direct electron efficiencies than GOx synthesized with single-carbon nanotubes and graphene, respectively. Based on this study, we propose that pristine graphene has the potential to develop glucose oxidase interfaces and carbon-nanotube–graphene composites for easy fabrication, low cost, and efficient electrode structures for enzyme-based biofuel cells. [ABSTRACT FROM AUTHOR]

In this paper, the Cu/Cu2O and Cu/Cu2O/CuO electrodes were successfully fabricated from the copper layer of a printed circuit board using an electrical oxidation method. The physical properties of these samples were verified through X-Ray diffraction and scanning electron microscopy (SEM) measurements. The Cu/Cu2O and Cu/CuO/Cu2O electrodes were employed as non-enzyme sensors for the detection of glucose in the alkaline solution. The properties of electrodes were investigated using cyclic voltammetry and amperometry measurements with glucose solution. The results show that both types of electrodes can detect and quantify glucose concentrations. The Cu/Cu2O/CuO composite electrode demonstrated superior performance compared to the Cu/Cu2O electrode. The proposed sensor demonstrated a limit of detection of approximately 63.08 nM. Additionally, the proposed sensor was also investigated with various interfering substances, including ascorbic acid, urea, and table salt. The results revealed that the current intensity remained nearly unchanged for these substances, while it significantly increased from 0.3 to 2.5 mA/cm2 for glucose. With these achieved results, the developed system shows promise for application in glucose testing systems, benefiting diabetic patients in the future. [ABSTRACT FROM AUTHOR]

A simple and low-cost green preparation method was used for BSA capped silver nanoclusters (BSA-Ag NCs) as turn on fluorescent probe for glucose. Non-enzymatic fast glucose detection assay with a widest concentration range was proposed which requires neither nanoclusters (NCs) modification nor complicated enzyme immobilization. The DLS analysis, HRTEM patterns, fluorescence and UV-visible measurement well supported the synthesis product. The advantages of the fabricated glucose sensor based on fluorescence increasing of probe compared to other established optical techniques was inspected and summarized as well. The glucose sensor exhibited a high sensitivity, fast response time (in seconds), satisfactory selectivity, well stability (at least two months), low detection limit (31 µmol L− 1) and a wide concentration response (three orders of magnitudes) to glucose between 0.1 and 92 mmol L− 1 as calibration plot. A theoretical model of the sensing mechanism based on the binding interaction of glucose to BSA-Ag NCs is proposed and data fitting demonstrated a good agreement between the experimental and theoretically calculated fluorescence data. The facile preparation and excellent sensing performance of BSA-Ag NCs in the real samples (plasma and juice) make sure that synthesized probe material is a promising candidate for advanced enzyme-free glucose sensing approach. [ABSTRACT FROM AUTHOR]

The money-chain-like superstructure Ni-MOF nanomaterial catalyzes glucose, and the transformation processes of substances in glucose and the reaction system are thoroughly analyzed using multiple in-situ techniques, particularly the generation of NiOOH and the conversion of glucose to either glucose acid or gluconlactone, revealing important reaction mechanisms. [Display omitted] • Successfully synthesized money-chain-like superstructure Ni-MOF nanomaterials at room temperature and applied them to glucose electrochemical sensors. • Conducted in-depth research on the reaction mechanisms of Ni-MOF in glucose detection using techniques such as synchrotron radiation, in-situ Raman spectroscopy, and in-situ UV–visible spectrophotometry. • The reaction process between the generation of NiOOH and the conversion of glucose to gluconic acid was observed. • The conversion of glucose to either glucose acid or gluconlactone, revealing important reaction mechanisms. The design and synthesis of efficient electrochemical sensors are crucial transformation technologies in electrochemistry. We successfully synthesize a three-dimensional Ni-metal–organic framework (MOF) nanostructured material with a superior architecture using benzimidazole and nickel nitrate as precursors at room temperature which is being applied in glucose electrochemical sensors. The reaction mechanism of M-6 during glucose detection is thoroughly studied using various characterization techniques, such as in situ Raman spectroscopy, in situ ultraviolet–visible spectrophotometry, synchrotron radiography, X-ray diffraction, X-ray photoelectron spectroscopy, and scanning electron microscopy. The research findings demonstrate that the M-6 material exhibits high sensitivity for glucose detection, with a sensitivity of 2199.88 mA M−1 cm−2. This study provides an important reference for designing more efficient electrochemical reaction systems and optimizing material performance. Furthermore, the superstructural design offers new ideas and possibilities for the development and application of similar materials. [ABSTRACT FROM AUTHOR]

Hydrogel-based technologies have emerged as transformative tools in the management of diabetes, offering novel solutions in both drug delivery and diagnostic techniques. Diabetes, a chronic metabolic disorder characterized by elevated blood glucose levels, necessitates precise and consistent therapeutic interventions to mitigate its complications and improve patient outcomes. This abstract explores recent innovations in hydrogel applications tailored for diabetes care, focusing on advanced drug delivery systems and flexible diagnostic techniques. Hydrogels, three-dimensional networks of hydrophilic polymers capable of absorbing and retaining large amounts of water, exhibit properties that make them ideal candidates for biomedical applications. In drug delivery, hydrogels offer controlled release mechanisms that can mimic physiological conditions, enhancing the efficacy of therapeutics such as insulin and GLP-1 receptor agonists. Innovations in this area include stimuliresponsive hydrogels that release drugs in response to changes in glucose levels or other physiological cues, thereby improving glycemic control and patient compliance. Additionally, the development of injectable hydrogel formulations allows for sustained drug release, reducing the frequency of administrations and providing long-term therapeutic benefits. Furthermore, hydrogelbased diagnostic techniques have revolutionized diabetes management by enabling non-invasive and continuous monitoring of glucose levels. Hydrogel-based biosensors offer real-time monitoring capabilities, detecting glucose and other biomarkers through wearable devices or integrated patches. These sensors leverage the biocompatibility and flexibility of hydrogels to adhere comfortably to the skin, ensuring prolonged and accurate monitoring without the discomfort associated with traditional methods. Moreover, advancements in microneedle technology have facilitated minimally invasive glucose monitoring, with hydrogel-based microneedle patches capable of sampling interstitial fluid for glucose analysis. [ABSTRACT FROM AUTHOR]

In this study, we investigated the influence of pH on the hydrothermal synthesis of copper (II) oxide CuO nanostructures with the aim of tuning their morphology. By varying the pH of the reaction medium, we successfully produced CuO nanostructures with three distinct morphologies including nanoparticles, nanorods, and nanosheets according to the pH levels of 4, 7, and 12, respectively. The observed variations in surface morphology are attributed to fluctuations in growth rates across different crystal facets, which are influenced by the presence of intermediate species within the reaction. This report also compared the structural and optical properties of the synthesized CuO nanostructures and explored their potential for photoelectrochemical glucose sensing. Notably, CuO nanoparticles and nanorods displayed exceptional performance with calculated limits of detection of 0.69 nM and 0.61 nM, respectively. Both of these morphologies exhibited a linear response to glucose within their corresponding concentration ranges (3–20 nM and 20–150 nM). As a result, CuO nanorods appear to be a more favorable photoelectrochemical sensing method because of the large surface area as well as the lowest solution resistance in electroimpedance analysis compared to CuO nanoparticles and nanosheets forms. These findings strongly suggest the promising application of hydrothermal-synthesized CuO nanostructures for ultrasensitive photoelectrochemical glucose biosensors. [ABSTRACT FROM AUTHOR]

Non-functioning adrenal incidentalomas (NFAIs) have been placed in relationship with a higher risk of glucose profile anomalies, while the full-blown typical picture of Cushing's syndrome (CS) and associated secondary (glucocorticoid-induced) diabetes mellitus is not explicitly confirmed in this instance. Our objective was to highlight the most recent data concerning the glucose profile, particularly, type 2 diabetes mellitus (T2DM) in NFAIs with/without mild autonomous cortisol secretion (MACS). This was a comprehensive review of the literature; the search was conducted according to various combinations of key terms. We included English-published, original studies across a 5-year window of publication time (from January 2020 until 1 April 2024) on PubMed. We excluded case reports, reviews, studies on T1DM or secondary diabetes, and experimental data. We identified 37 studies of various designs (14 retrospective studies as well 13 cross-sectional, 4 cohorts, 3 prospective, and 2 case–control studies) that analysed 17,391 individuals, with a female-to-male ratio of 1.47 (aged between 14 and 96 years). T2DM prevalence in MACS (affecting 10 to 30% of NFAIs) ranged from 12% to 44%. The highest T2DM prevalence in NFAI was 45.2% in one study. MACS versus (non-MACS) NFAIs (n = 16) showed an increased risk of T2DM and even of prediabetes or higher fasting plasma glucose or HbA1c (no unanimous results). T2DM prevalence was analysed in NFAI (N = 1243, female-to-male ratio of 1.11, mean age of 60.42) versus (non-tumour) controls (N = 1548, female-to-male ratio of 0.91, average age of 60.22) amid four studies, and two of them were confirmatory with respect to a higher rate in NFAIs. Four studies included a sub-group of CS compared to NFAI/MACS, and two of them did not confirm an increased rate of glucose profile anomalies in CS versus NFAIs/ACS. The longest period of follow-up with concern to the glycaemic profile was 10.5 years, and one cohort showed a significant increase in the T2DM rate at 17.9% compared to the baseline value of 0.03%. Additionally, inconsistent data from six studies enrolling 1039 individuals that underwent adrenalectomy (N = 674) and conservative management (N = 365) pinpointed the impact of the surgery in NFAIs. The regulation of the glucose metabolism after adrenalectomy versus baseline versus conservative management (n = 3) was improved. To our knowledge, this comprehensive review included one of the largest recent analyses in the field of glucose profile amid the confirmation of MACS/NFAI. In light of the rising incidence of NFAI/AIs due to easier access to imagery scans and endocrine evaluation across the spectrum of modern medicine, it is critical to assess if these patients have an increased frequency of cardio-metabolic disorders that worsen their overall comorbidity and mortality profile, including via the confirmation of T2DM. [ABSTRACT FROM AUTHOR]

Background: Efficient monitoring of glucose concentration in the human body necessitates the utilization of electrochemically active sensing materials in nonenzymatic glucose sensors. However, prevailing limitations such as intricate fabrication processes, lower sensitivity, and instability impede their practical application. Herein, ternary Cu-Co-Ni-S sulfides nanoporous network structure was synthesized on carbon fiber paper (CP) by an ultrafast, facile, and controllable technique through on-step cyclic voltammetry, serving as a superior self-supporting catalytic electrode for the high-performance glucose sensor. Results: The direct growth of free-standing Cu-Co-Ni-S on the interconnected three-dimensional (3D) network of CP boosted the active site of the composites, improved ion diffusion kinetics, and significantly promoted the electron transfer rate. The multiple oxidation states and synergistic effects among Co, Ni, Cu, and S further promoted glucose electrooxidation. The well-architected Cu-Co-Ni-S/CP presented exceptional electrocatalytic properties for glucose with satisfied linearity of a broad range from 0.3 to 16,000 μM and high sensitivity of 6829 μA mM− 1 cm− 2. Furthermore, the novel sensor demonstrated excellent selectivity and storage stability, which could successfully evaluate the glucose levels in human serum. Notably, the novel Cu-Co-Ni-S/CP showed favorable biocompatibility, proving its potential for in vivo glucose monitoring. Conclusion: The proposed 3D hierarchical morphology self-supported electrode sensor, which demonstrates appealing analysis behavior for glucose electrooxidation, holds great promise for the next generation of high-performance glucose sensors. [ABSTRACT FROM AUTHOR]

The New Journal of Chemistry, published by The Royal Society of Chemistry, has released its latest issue containing a variety of articles and papers on chemistry-related topics. The journal aims to connect the world with the chemical sciences and features papers on bioethanol fermentation, hydrogels in energy storage and biomedical technologies, environmentally responsible production, and other subjects. The document is a list of papers published in the journal, covering topics such as metal-organic frameworks, cycloaddition reactions, photochromic films, supercapacitors, computational predictions, catalysis, nanospheres, electrochemical sensors, and quantum dots. These papers offer valuable insights and advancements in the fields of chemistry and materials science. [Extracted from the article]

Here, ternary layer hydroxide (NiCoFe-LDH) nanosheets have been grafted in situ onto graphene oxide (GO) using a one-pot hydrothermal method to obtain NiCoFe-LDH/GO for the fabrication of a non-enzymatic glucose sensor with high stability. SEM analysis shows that ternary LDHs with a nanosheet layer structure grow on GO at an angle with less stacking, thus imparting NiCoFe-LDH/GO with a large specific surface area (112.32 m2 g−1) that exposes more active sites. The results of cyclic voltammetry (CV) and chronoamperometry (CA) studies show that NiCoFe-LDH/GO/GCE displays a wide linear detection range of 0.005–7.54 mM, a sensitivity of 196.18 μA cm−2 mM−1, and a low detection limit of 0.41 μM (S/N = 3). In particular, NiCoFe-LDH/GO/GCE has high stability, that is, it still holds 90.2% of its initial value even after 90 days. Meanwhile, the study results demonstrate that the NiCoFe-LDH/GO/GCE electrode is suitable for the detection of glucose in artificial saliva, and it also reveals a good recovery ranging from 95.6% to 105.5% in actual saliva. Therefore, NiCoFe-LDH/GO is anticipated to be an ideal sensing material for the creation of noninvasive enzyme-free glucose sensors. [ABSTRACT FROM AUTHOR]

Glycerol is a widely used signaling bioanalyte in biotechnology. Glycerol can serve as a substrate or product of many metabolic processes in cells. Therefore, quantification of glycerol in fermentation samples with inexpensive, reliable, and rapid sensing systems is of great importance. In this work, an amperometric assay based on one-step designed electroplated functional Pd layers with controlled design was proposed for a rapid and selective measurement of glycerol in yeast fermentation medium. A novel assay utilizing electroplated Pd-sensing layers allows the quantification of glycerol in yeast fermentation medium in the presence of interfering species with RSD below 3% and recoveries ranged from 99 to 103%. The assay requires minimal sample preparation, viz. adjusting of sample pH to 12. The time taken to complete the electrochemical analysis was 3 min. Remarkably, during investigations, it was revealed that sensitivity and selectivity of glycerol determination on Pd sensors were significantly affected by its adsorption and did not depend on the surface structure of sensing layers. This study is expected to contribute to both fundamental and practical research fields related to a preliminary choice of functional sensing layers for specific biotechnology and life science applications in the future. [ABSTRACT FROM AUTHOR]

Raman spectroscopy offers a rapid and nondestructive method for qualitatively and quantitatively analyzing the molecular structure of substances. Herein, a facile and cost‐effective approach for the preparation of three‐dimensional (3D) surface‐enhanced Raman scattering (SERS) substrates is proposed, in which pyramid structures are fabricated using silicon anisotropic wet etching and silver dendrites are decorated on these silicon pyramid (PSi) substrates by immersing them in a mixture of hydrofluoric acid and silver nitrate for several minutes. The 3D SERS substrates, based on PSi coated with Ag dendrites, reveal high‐performance SERS enhancement (with an analytical enhancement factor reaching 3.54 × 1010) and can detect rhodamine 6G (R6G) in the presence of chemical enhancer (lithium chloride) at low concentrations down to 10−11 m. For glucose detection, 2‐thienylboronic acid is employed to faciliate glucose attachment to the substrate surface, achieving a detection limit as low as 10−6 m. The substrate exhibits good repeatability with a relative standard deviation of 11.223%, as well as reusability and long‐term stability for detection. The results also highlight the excellent sensitivity of the PSi‐based SERS substrate, which is expected to be instrumental in biochemical analysis and holds significant potential for developing noninvasive glucose sensor for diabetic patients using saliva samples. [ABSTRACT FROM AUTHOR]

The present study aims to explore the etiology of Diabetic osteoporosis (DOP), a chronic complication associated with diabetes mellitus. Specifically, the research seeks to identify potential miRNA biomarkers of DOP and investigated role in regulating osteoblasts. To achieve this, an animal model of DOP was established through the administration of a high-sugar and high-fat diet, and then injection of streptozotocin. Bone microarchitecture and histopathology analysis were analyzed. Rat calvarial osteoblasts (ROBs) were stimulated with high glucose (HG). MiRNA profiles of the stimulated osteoblasts were compared to control osteoblasts using sequencing. Proliferation and mineralization abilities were assessed using MTT assay, alkaline phosphatase, and alizarin red staining. Expression levels of OGN, Runx2, and ALP were determined through qRT-PCR and Western blot. MiRNA-sequencing results revealed increased miRNA-702-5p levels. Luciferase reporter gene was utilized to study the correlation between miR-702-5p and OGN. High glucose impaired cell proliferation and mineralization in vitro by inhibiting OGN, Runx2, and ALP expressions. Interference with miR-702-5p decreased OGN, Runx2, and ALP levels, which were restored by OGN overexpression. Additionally, downregulation of OGN and Runx2 in DOP rat femurs was confirmed. Therefore, the miRNA-702-5p/OGN/Runx2 signaling axis may play a role in DOP, and could be diagnostic biomarker and therapeutic target for not only DOP but also other forms of osteoporosis. [ABSTRACT FROM AUTHOR]

Background: Association between glucose and inflammatory bowel disease (IBD) was found in previous observational studies and in cohort studies. However, it is not clear whether these associations reflect causality. Thus, this study investigated whether there is such a causal relation between elevated glucose and IBD, Crohn's disease (CD) and ulcerative colitis (UC). Methods: We performed a two-sample Mendelian Randomization (MR) with the independent genetic instruments identified from the largest available genome-wide association study (GWAS) for IBD (5,673 cases; 213,119 controls) and its main subtypes, CD and UC. Summarized data for glucose which included 200,622 cases and glycemic traits including HbA1c and type 2 diabetes(T2DM) were obtained from different GWAS studies. Primary and secondary analyses were conducted by preferentially using the radial inverse-variance weighted (IVW) approach. A number of other meta-analysis approach and sensitivity analyses were carried out to assess the robustness of the results. Results: We did not find a causal effect of genetically predicted glucose on IBD as a whole (OR 0.858; 95% CI 0.649–1.135; P = 0.286). In subtype analyses glucose was also suggestively not associated with Crohn's disease (OR 0.22; 95% CI 0.04-1.00; P = 0.05) and ulcerative colitis (OR 0.940; 95% CI 0.628–1.407; P = 0.762). In the other direction, IBD and its subtypes were not related to glucose and glycemic traits. Conclusions: This MR study is not providing any evidence for a causal relationship between genetically predicted elevated glucose and IBD as well as it's subtypes UC and CD. Regarding the other direction, no causal associations could be found. Future studies with robust genetic instruments are needed to confirm this conclusion. [ABSTRACT FROM AUTHOR]